Kane Biotech Inc (KNE) — Cash Flow Quality Index
Latest as of June 2024:
-0.24x
Kane Biotech Inc (KNE) has a Cash Flow Quality Index of -0.24x as of June 2024. Operating cash flow of CA$-2.17 Million is below net income of CA$9.18 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore KNE debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
-0.24x
Operating CF / Net Income
Operating Cash Flow
CA$-2.17 Million
CAD
Net Income
CA$9.18 Million
CAD
Data as of
Jun 2024
Most recent filing
Kane Biotech Inc Cash Flow Quality Index (2024–2024)
Historical Cash Flow Quality Index for Kane Biotech Inc across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see Kane Biotech Inc cash flow conversion.
Annual Cash Flow Quality Index for Kane Biotech Inc (2024–2024)
Year-by-year earnings quality comparison for Kane Biotech Inc.
| Year | Quality Index | Operating CF (CAD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | -0.67x | CA$-4.11 Million | CA$6.10 Million | — |
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.